C8..
CANCELLED SEC. 8 (6-YR)
08/14/2026
Back to search
Official data from USPTO
MAYO CLINIC GENEGUIDE
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (6-YR)Type: WordOffice: United States
Quick snapshot
MAYO CLINIC GENEGUIDE
ST13
US500000087405960Class
42
Filing
87405960
Registration
5978581
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (6-YR)
Case type
Application and registration
Recorded events
43
Latest update
08/14/2026
Trademark type
Word
Nice classes
42
Filing date
04/10/2017
Registration date
02/04/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/14/2026
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/28/2018
First use in commerce
10/02/2018
Drawing code
4
Owner type
99
Owner location
Rochester, MN, US
Examiner
POWERS, ALEXANDER L
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mayo Foundation for Medical Education and Research
Representatives
Timothy M. Kenny Norton Rose Fulbright US LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
DNA screening and genetic testing for medical and scientific research purposes; providing medical and scientific research information and online databases in the field of geneticsgenetic testing and genomics
Publications
History of USPTO decisions and trademark events.
43 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/13/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/13/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/01/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/31/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/30/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/28/2019
IUAF
USE AMENDMENT FILED
12/18/2019
EISU
TEAS STATEMENT OF USE RECEIVED
12/18/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/14/2019
EX3G
SOU EXTENSION 3 GRANTED
05/10/2019
EXT3
SOU EXTENSION 3 FILED
05/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/25/2018
EX2G
SOU EXTENSION 2 GRANTED
12/22/2018
EXT2
SOU EXTENSION 2 FILED
12/22/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/22/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/14/2018
EX1G
SOU EXTENSION 1 GRANTED
06/12/2018
EXT1
SOU EXTENSION 1 FILED
06/12/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/12/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/26/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2017
PUBO
PUBLISHED FOR OPPOSITION
10/31/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/21/2017
ALIE
ASSIGNED TO LIE
09/21/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/21/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/21/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/21/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/30/2017
GPRA
PRIORITY ACTION E-MAILED
06/30/2017
CPRA
PRIORITY ACTION WRITTEN
06/30/2017
DOCK
ASSIGNED TO EXAMINER
06/29/2017
MPMK
NOTICE OF PSEUDO MARK E-MAILED
04/18/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/17/2017
NWAP
NEW APPLICATION ENTERED
04/13/2017
Continuous trademark protection
Get notified about every new filing that threatens MAYO CLINIC GENEGUIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.